Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs

NCT00634985 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: eletriptan

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.